Microbiology Spectrum-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2139197, encodeId=b606213919ebf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：1月初投稿，找编辑找了近一个月，后面找审稿人也是不太顺利，好在3月底第一轮意见返回...... 统计学的和专业方向的意见都有，提的比较细，但是总的来说比较友好。 耗时1个月补实验+返修，三周之后接收。总耗时大约4个月，毕业友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/bbb9a8ebfdef0a1265f60552e75e435f.jpg, createdBy=ebb42195493, createdName=Tzx5967, createdTime=Fri May 26 15:58:28 CST 2023, time=2023-05-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2146183, encodeId=c1e72146183c7, content=最新2022影响因子3.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Mon Jul 03 23:04:00 CST 2023, time=2023-07-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125105, encodeId=b5682125105c4, content=实时影响因子只有3+了，还能继续投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e3c8489384, createdName=ms4000000779831484, createdTime=Tue Apr 11 14:29:53 CST 2023, time=2023-04-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1209181, encodeId=24851209181cf, content=请问Under Evaluation一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Thu Apr 07 10:51:57 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123857, encodeId=3d16212385e5f, content=万古神帝 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d48a5610092, createdName=ms8000001013802309, createdTime=Wed Apr 05 10:26:32 CST 2023, time=2023-04-05, status=1, ipAttribution=重庆)]

2022-05-21 可乐与红茶

请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view

33 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2139197, encodeId=b606213919ebf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：1月初投稿，找编辑找了近一个月，后面找审稿人也是不太顺利，好在3月底第一轮意见返回...... 统计学的和专业方向的意见都有，提的比较细，但是总的来说比较友好。 耗时1个月补实验+返修，三周之后接收。总耗时大约4个月，毕业友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/bbb9a8ebfdef0a1265f60552e75e435f.jpg, createdBy=ebb42195493, createdName=Tzx5967, createdTime=Fri May 26 15:58:28 CST 2023, time=2023-05-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2146183, encodeId=c1e72146183c7, content=最新2022影响因子3.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Mon Jul 03 23:04:00 CST 2023, time=2023-07-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125105, encodeId=b5682125105c4, content=实时影响因子只有3+了，还能继续投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e3c8489384, createdName=ms4000000779831484, createdTime=Tue Apr 11 14:29:53 CST 2023, time=2023-04-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1209181, encodeId=24851209181cf, content=请问Under Evaluation一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Thu Apr 07 10:51:57 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123857, encodeId=3d16212385e5f, content=万古神帝 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d48a5610092, createdName=ms8000001013802309, createdTime=Wed Apr 05 10:26:32 CST 2023, time=2023-04-05, status=1, ipAttribution=重庆)]

2023-09-22 146ee135m37暂无昵称来自广东省

审稿速度:24.0 | 投稿命中率:5.0
偏重的研究方向：感染
经验分享：在evaluation和peer review之间反复变换怎么回事？求解答

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2139197, encodeId=b606213919ebf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：1月初投稿，找编辑找了近一个月，后面找审稿人也是不太顺利，好在3月底第一轮意见返回...... 统计学的和专业方向的意见都有，提的比较细，但是总的来说比较友好。 耗时1个月补实验+返修，三周之后接收。总耗时大约4个月，毕业友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/bbb9a8ebfdef0a1265f60552e75e435f.jpg, createdBy=ebb42195493, createdName=Tzx5967, createdTime=Fri May 26 15:58:28 CST 2023, time=2023-05-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2146183, encodeId=c1e72146183c7, content=最新2022影响因子3.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Mon Jul 03 23:04:00 CST 2023, time=2023-07-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125105, encodeId=b5682125105c4, content=实时影响因子只有3+了，还能继续投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e3c8489384, createdName=ms4000000779831484, createdTime=Tue Apr 11 14:29:53 CST 2023, time=2023-04-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1209181, encodeId=24851209181cf, content=请问Under Evaluation一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Thu Apr 07 10:51:57 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123857, encodeId=3d16212385e5f, content=万古神帝 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d48a5610092, createdName=ms8000001013802309, createdTime=Wed Apr 05 10:26:32 CST 2023, time=2023-04-05, status=1, ipAttribution=重庆)]

2022-10-11 121e5ed5m66(暂无昵称)

偏重的研究方向：微生物
经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息

49 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2139197, encodeId=b606213919ebf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：1月初投稿，找编辑找了近一个月，后面找审稿人也是不太顺利，好在3月底第一轮意见返回...... 统计学的和专业方向的意见都有，提的比较细，但是总的来说比较友好。 耗时1个月补实验+返修，三周之后接收。总耗时大约4个月，毕业友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/bbb9a8ebfdef0a1265f60552e75e435f.jpg, createdBy=ebb42195493, createdName=Tzx5967, createdTime=Fri May 26 15:58:28 CST 2023, time=2023-05-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2146183, encodeId=c1e72146183c7, content=最新2022影响因子3.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Mon Jul 03 23:04:00 CST 2023, time=2023-07-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125105, encodeId=b5682125105c4, content=实时影响因子只有3+了，还能继续投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e3c8489384, createdName=ms4000000779831484, createdTime=Tue Apr 11 14:29:53 CST 2023, time=2023-04-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1209181, encodeId=24851209181cf, content=请问Under Evaluation一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Thu Apr 07 10:51:57 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123857, encodeId=3d16212385e5f, content=万古神帝 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d48a5610092, createdName=ms8000001013802309, createdTime=Wed Apr 05 10:26:32 CST 2023, time=2023-04-05, status=1, ipAttribution=重庆)]

2023-09-21 浩浩Peter 来自内蒙古

缴费以后多久收到proof呀还有proof之后多久online

23 0

[GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2139197, encodeId=b606213919ebf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：1月初投稿，找编辑找了近一个月，后面找审稿人也是不太顺利，好在3月底第一轮意见返回...... 统计学的和专业方向的意见都有，提的比较细，但是总的来说比较友好。 耗时1个月补实验+返修，三周之后接收。总耗时大约4个月，毕业友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/bbb9a8ebfdef0a1265f60552e75e435f.jpg, createdBy=ebb42195493, createdName=Tzx5967, createdTime=Fri May 26 15:58:28 CST 2023, time=2023-05-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2146183, encodeId=c1e72146183c7, content=最新2022影响因子3.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Mon Jul 03 23:04:00 CST 2023, time=2023-07-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125105, encodeId=b5682125105c4, content=实时影响因子只有3+了，还能继续投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e3c8489384, createdName=ms4000000779831484, createdTime=Tue Apr 11 14:29:53 CST 2023, time=2023-04-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1209181, encodeId=24851209181cf, content=请问Under Evaluation一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Thu Apr 07 10:51:57 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123857, encodeId=3d16212385e5f, content=万古神帝 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d48a5610092, createdName=ms8000001013802309, createdTime=Wed Apr 05 10:26:32 CST 2023, time=2023-04-05, status=1, ipAttribution=重庆)]

2023-08-05 ms8000001329067303 来自宁夏

偏重的研究方向：天然药物
经验分享：已投，未知

30 0

[GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2139197, encodeId=b606213919ebf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：1月初投稿，找编辑找了近一个月，后面找审稿人也是不太顺利，好在3月底第一轮意见返回...... 统计学的和专业方向的意见都有，提的比较细，但是总的来说比较友好。 耗时1个月补实验+返修，三周之后接收。总耗时大约4个月，毕业友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/bbb9a8ebfdef0a1265f60552e75e435f.jpg, createdBy=ebb42195493, createdName=Tzx5967, createdTime=Fri May 26 15:58:28 CST 2023, time=2023-05-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2146183, encodeId=c1e72146183c7, content=最新2022影响因子3.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Mon Jul 03 23:04:00 CST 2023, time=2023-07-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125105, encodeId=b5682125105c4, content=实时影响因子只有3+了，还能继续投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e3c8489384, createdName=ms4000000779831484, createdTime=Tue Apr 11 14:29:53 CST 2023, time=2023-04-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1209181, encodeId=24851209181cf, content=请问Under Evaluation一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Thu Apr 07 10:51:57 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123857, encodeId=3d16212385e5f, content=万古神帝 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d48a5610092, createdName=ms8000001013802309, createdTime=Wed Apr 05 10:26:32 CST 2023, time=2023-04-05, status=1, ipAttribution=重庆)]

2023-05-26 Tzx5967 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：微生物
经验分享：1月初投稿，找编辑找了近一个月，后面找审稿人也是不太顺利，好在3月底第一轮意见返回......
统计学的和专业方向的意见都有，提的比较细，但是总的来说比较友好。
耗时1个月补实验+返修，三周之后接收。总耗时大约4个月，毕业友好

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2139197, encodeId=b606213919ebf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：1月初投稿，找编辑找了近一个月，后面找审稿人也是不太顺利，好在3月底第一轮意见返回...... 统计学的和专业方向的意见都有，提的比较细，但是总的来说比较友好。 耗时1个月补实验+返修，三周之后接收。总耗时大约4个月，毕业友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/bbb9a8ebfdef0a1265f60552e75e435f.jpg, createdBy=ebb42195493, createdName=Tzx5967, createdTime=Fri May 26 15:58:28 CST 2023, time=2023-05-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2146183, encodeId=c1e72146183c7, content=最新2022影响因子3.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Mon Jul 03 23:04:00 CST 2023, time=2023-07-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125105, encodeId=b5682125105c4, content=实时影响因子只有3+了，还能继续投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e3c8489384, createdName=ms4000000779831484, createdTime=Tue Apr 11 14:29:53 CST 2023, time=2023-04-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1209181, encodeId=24851209181cf, content=请问Under Evaluation一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Thu Apr 07 10:51:57 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123857, encodeId=3d16212385e5f, content=万古神帝 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d48a5610092, createdName=ms8000001013802309, createdTime=Wed Apr 05 10:26:32 CST 2023, time=2023-04-05, status=1, ipAttribution=重庆)]

2023-07-03 jobhnw 来自安徽省

最新2022影响因子3.7

106 0

[GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2139197, encodeId=b606213919ebf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：1月初投稿，找编辑找了近一个月，后面找审稿人也是不太顺利，好在3月底第一轮意见返回...... 统计学的和专业方向的意见都有，提的比较细，但是总的来说比较友好。 耗时1个月补实验+返修，三周之后接收。总耗时大约4个月，毕业友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/bbb9a8ebfdef0a1265f60552e75e435f.jpg, createdBy=ebb42195493, createdName=Tzx5967, createdTime=Fri May 26 15:58:28 CST 2023, time=2023-05-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2146183, encodeId=c1e72146183c7, content=最新2022影响因子3.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Mon Jul 03 23:04:00 CST 2023, time=2023-07-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125105, encodeId=b5682125105c4, content=实时影响因子只有3+了，还能继续投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e3c8489384, createdName=ms4000000779831484, createdTime=Tue Apr 11 14:29:53 CST 2023, time=2023-04-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1209181, encodeId=24851209181cf, content=请问Under Evaluation一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Thu Apr 07 10:51:57 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123857, encodeId=3d16212385e5f, content=万古神帝 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d48a5610092, createdName=ms8000001013802309, createdTime=Wed Apr 05 10:26:32 CST 2023, time=2023-04-05, status=1, ipAttribution=重庆)]

2023-04-11 ms4000000779831484 来自天津

实时影响因子只有3+了，还能继续投吗？

55 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2139197, encodeId=b606213919ebf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：1月初投稿，找编辑找了近一个月，后面找审稿人也是不太顺利，好在3月底第一轮意见返回...... 统计学的和专业方向的意见都有，提的比较细，但是总的来说比较友好。 耗时1个月补实验+返修，三周之后接收。总耗时大约4个月，毕业友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/bbb9a8ebfdef0a1265f60552e75e435f.jpg, createdBy=ebb42195493, createdName=Tzx5967, createdTime=Fri May 26 15:58:28 CST 2023, time=2023-05-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2146183, encodeId=c1e72146183c7, content=最新2022影响因子3.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Mon Jul 03 23:04:00 CST 2023, time=2023-07-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125105, encodeId=b5682125105c4, content=实时影响因子只有3+了，还能继续投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e3c8489384, createdName=ms4000000779831484, createdTime=Tue Apr 11 14:29:53 CST 2023, time=2023-04-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1209181, encodeId=24851209181cf, content=请问Under Evaluation一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Thu Apr 07 10:51:57 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123857, encodeId=3d16212385e5f, content=万古神帝 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d48a5610092, createdName=ms8000001013802309, createdTime=Wed Apr 05 10:26:32 CST 2023, time=2023-04-05, status=1, ipAttribution=重庆)]

2022-04-07 1821e90a65m

请问Under Evaluation一般要多久？

66 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2139197, encodeId=b606213919ebf, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：1月初投稿，找编辑找了近一个月，后面找审稿人也是不太顺利，好在3月底第一轮意见返回...... 统计学的和专业方向的意见都有，提的比较细，但是总的来说比较友好。 耗时1个月补实验+返修，三周之后接收。总耗时大约4个月，毕业友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/bbb9a8ebfdef0a1265f60552e75e435f.jpg, createdBy=ebb42195493, createdName=Tzx5967, createdTime=Fri May 26 15:58:28 CST 2023, time=2023-05-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2146183, encodeId=c1e72146183c7, content=最新2022影响因子3.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9be1604114, createdName=jobhnw, createdTime=Mon Jul 03 23:04:00 CST 2023, time=2023-07-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2125105, encodeId=b5682125105c4, content=实时影响因子只有3+了，还能继续投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e3c8489384, createdName=ms4000000779831484, createdTime=Tue Apr 11 14:29:53 CST 2023, time=2023-04-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1209181, encodeId=24851209181cf, content=请问Under Evaluation一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Thu Apr 07 10:51:57 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123857, encodeId=3d16212385e5f, content=万古神帝 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d48a5610092, createdName=ms8000001013802309, createdTime=Wed Apr 05 10:26:32 CST 2023, time=2023-04-05, status=1, ipAttribution=重庆)]

2023-04-05 ms8000001013802309 来自重庆

万古神帝

49 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务